M05.479

Clinical Causes: Autoimmune response inherent to rheumatoid arthritis causes inflammation in joints and muscles. Genetic factors that predispose individuals to autoimmune disorders. Environmental triggers such as smoking, infections, or stress that may initiate or exacerbate immune dysregulation. Chronic systemic inflammation associated with rheumatoid arthritis. Prolonged or uncontrolled RA leading to secondary muscle involvement.

Key Symptoms: Muscle weakness, particularly in the muscles around the ankles and feet. Muscle pain and tenderness in affected areas. Swelling and inflammation around the ankle and foot joints. Reduced mobility and difficulty walking due to joint and muscle involvement. Fatigue and general feelings of malaise. Possible stiffness in the muscles, especially after periods of inactivity. Visible or palpable inflammation in the affected muscles and joints.

Diagnosis Path: A physical examination focusing on muscle strength and joint mobility. Blood tests to identify markers of inflammation, such as ESR or CRP, and rheumatoid factor (RF). Imaging studies like X-rays, MRI, or ultrasound to assess joint and muscle involvement. Electromyography (EMG) to evaluate electrical activity in muscles, helping differentiate myopathy from other neurological conditions. Muscle biopsy in some cases to confirm inflammation and rule out other muscle diseases.

Treatment Protocols: Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression. Biologic agents targeting specific immune pathways to reduce inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief and inflammation reduction. Corticosteroids to quickly control severe inflammation. Physical therapy and exercise programs to maintain muscle strength and joint flexibility. Assistive devices or orthotics to support mobility if needed. Monitoring and managing comorbidities associated with RA.